Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study
- PMID: 10336124
- DOI: 10.1016/s0306-4522(98)00251-6
Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study
Abstract
The existence of at least three opioid receptor types, referred to as mu, kappa, and delta, is well established. Complementary DNAs corresponding to the pharmacologically defined mu, kappa, and delta opioid receptors have been isolated in various species including man. The expression patterns of opioid receptor transcripts in human brain has not been established with a cellular resolution, in part because of the low apparent abundance of opioid receptor messenger RNAs in human brain. To visualize opioid receptor messenger RNAs we developed a sensitive in situ hybridization histochemistry method using 33P-labelled RNA probes. In the present study we report the regional and cellular expression of mu, kappa, and delta opioid receptor messenger RNAs in selected areas of the human brain. Hybridization of the different opioid receptor probes resulted in distinct labelling patterns. For the mu and kappa opioid receptor probes, the most intense regional signals were observed in striatum, thalamus, hypothalamus, cerebral cortex, cerebellum and certain brainstem areas as well as the spinal cord. The most intense signals for the delta opioid receptor probe were found in cerebral cortex. Expression of opioid receptor transcripts was restricted to subpopulations of neurons within most regions studied demonstrating differences in the cellular expression patterns of mu, kappa, and delta opioid receptor messenger RNAs in numerous brain regions. The messenger RNA distribution patterns for each opioid receptor corresponded in general to the distribution of opioid receptor binding sites as visualized by receptor autoradiography. However, some mismatches, for instance between mu opioid receptor receptor binding and mu opioid receptor messenger RNA expression in the anterior striatum, were observed. A comparison of the distribution patterns of opioid receptor messenger RNAs in the human brain and that reported for the rat suggests a homologous expression pattern in many regions. However, in the human brain, kappa opioid receptor messenger RNA expression was more widely distributed than in rodents. The differential and region specific expression of opioid receptors may help to identify targets for receptor specific compounds in neuronal circuits involved in a variety of physiological functions including pain perception, neuroendocrine regulation, motor control and reward.
Similar articles
-
Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study.J Comp Neurol. 1994 Dec 15;350(3):412-38. doi: 10.1002/cne.903500307. J Comp Neurol. 1994. PMID: 7884049
-
Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA.Brain Res Mol Brain Res. 1995 Dec 28;34(2):209-20. doi: 10.1016/0169-328x(95)00165-o. Brain Res Mol Brain Res. 1995. PMID: 8750824
-
Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse.J Neurosci. 1998 Apr 1;18(7):2538-49. doi: 10.1523/JNEUROSCI.18-07-02538.1998. J Neurosci. 1998. PMID: 9502813 Free PMC article.
-
Molecular pharmacology of the opioid receptors.Pharmacol Ther. 1995;68(3):343-64. doi: 10.1016/0163-7258(95)02011-x. Pharmacol Ther. 1995. PMID: 8788562 Review.
-
Transcriptional and epigenetic regulation of opioid receptor genes: present and future.Annu Rev Pharmacol Toxicol. 2011;51:75-97. doi: 10.1146/annurev-pharmtox-010510-100605. Annu Rev Pharmacol Toxicol. 2011. PMID: 20868272 Free PMC article. Review.
Cited by
-
Chemogenetic Manipulation of Amygdala Kappa Opioid Receptor Neurons Modulates Amygdala Neuronal Activity and Neuropathic Pain Behaviors.Cells. 2024 Apr 19;13(8):705. doi: 10.3390/cells13080705. Cells. 2024. PMID: 38667320 Free PMC article.
-
Opioid modulation of prefrontal cortex cells and circuits.Neuropharmacology. 2024 May 1;248:109891. doi: 10.1016/j.neuropharm.2024.109891. Epub 2024 Feb 27. Neuropharmacology. 2024. PMID: 38417545 Review.
-
Anxious-depressive attack and rejection sensitivity-Toward a new approach to treatment-resistant depression.Neuropsychopharmacol Rep. 2024 Mar;44(1):17-28. doi: 10.1002/npr2.12399. Epub 2023 Dec 7. Neuropsychopharmacol Rep. 2024. PMID: 38059339 Free PMC article. Review.
-
The claustrum and consciousness: An update.Int J Clin Health Psychol. 2023 Oct-Dec;23(4):100405. doi: 10.1016/j.ijchp.2023.100405. Epub 2023 Sep 7. Int J Clin Health Psychol. 2023. PMID: 37701759 Free PMC article.
-
Neurotransmitter and receptor systems in the subthalamic nucleus.Brain Struct Funct. 2023 Sep;228(7):1595-1617. doi: 10.1007/s00429-023-02678-z. Epub 2023 Jul 21. Brain Struct Funct. 2023. PMID: 37479801 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials